These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10850109)

  • 21. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.
    Brunser AM; Illanes S; Lavados PM; Muñoz P; Cárcamo D; Hoppe A; Olavarria VV; Delgado I; Díaz V
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1140-5. PubMed ID: 23253534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
    Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
    Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital].
    Figueroa-Reyes T; Sáez M D; Mansilla L E; Sánchez V R; Nogales-Gaete J; Delgado B I
    Rev Med Chil; 2011 Sep; 139(9):1118-27. PubMed ID: 22215389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombolytic therapy of brain infarct: the end of beginning].
    Stam J; Koudstaal PJ; Franke CL; Kappelle LJ; Boiten J
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1028-32. PubMed ID: 10850103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should repeat thrombolysis be considered after early ischaemic stroke recurrence?
    Simpson MA; Dewey HM
    Int J Stroke; 2009 Aug; 4(4):237-8. PubMed ID: 19689747
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
    Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
    Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a stroke thrombolysis service within a tertiary neurosciences centre in the United Kingdom.
    McCormick MT; Reeves I; Baird T; Bone I; Muir KW
    QJM; 2008 Apr; 101(4):291-8. PubMed ID: 18256038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
    Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellar vermis: a vulnerable location of remote brain haemorrhages after thrombolysis for ischaemic stroke.
    Tejada-Meza H; Modrego PJ
    Neurol Sci; 2017 Jan; 38(1):185-187. PubMed ID: 27709302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ; van der Worp HB
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of hemorrhagic transformation in acute ischaemic stroke by micro- and macroalbuminuria after intravenous thrombolysis.
    Cho BH; Kim JT; Chang J; Choi KH; Park MS; Cho KH
    Eur J Neurol; 2013 Aug; 20(8):1145-52. PubMed ID: 23582041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.